InvestorsHub Logo
Followers 468
Posts 26929
Boards Moderated 2
Alias Born 09/11/2006

Re: None

Tuesday, 08/04/2009 10:16:17 AM

Tuesday, August 04, 2009 10:16:17 AM

Post# of 400
James W. Fordyce Named to Ore Pharmaceuticals Board of Directors
Press Release
Source: Ore Pharmaceuticals Inc.
On Monday August 3, 2009, 5:33 pm EDT

Companies:Ore Pharmaceuticals Inc.
GAITHERSBURG, Md.--(BUSINESS WIRE)--Ore Pharmaceuticals Inc. (Nasdaq: ORXE - News), announced today the appointment of James W. Fordyce to its Board of Directors, as of July 31, 2009.

Mark J. Gabrielson, CEO and President of Ore, said, “Jim Fordyce is a wonderful addition to our Board. He has expertise in corporate development, public finance, health sciences venture capital and acquisitions. His investment and management track records have been highly successful over a long period of time. On top of all that, Jim’s dedication to the support and development of medical research through his life-long commitment to the Albert and Mary Lasker Foundation, Inc. shows that he holds progress in human health as a personal priority. We at Ore are delighted that he’s joining us.”

Mr. Fordyce is currently Managing Partner of MEDNA Partners LLC, a private advisory firm. From 1981 to 2004, he was a general partner of Prince Ventures LP, a venture capital management firm focused on investments in medicine and the life sciences. His early investments include Genentech, Applied Biosystems, Centocor and Regeneron Pharmaceuticals amongst other noteworthy health sciences companies. From 1998 to 2004, Mr. Fordyce also served as the Managing Member of Fordyce & Gabrielson LLC, a private investment management firm. He is currently a member of the Board of Directors of Dyax Corp. and several privately held companies. He is Chairman Emeritus of the Board of Directors of the Albert and Mary Lasker Foundation. Mr. Fordyce is a graduate of the University of Pennsylvania, Magdalen College, Oxford University and holds an MBA from Harvard Business School.

Mr. Fordyce said, “I am pleased to be joining the Board of Ore Pharmaceuticals as the company begins its exciting transformation into a pharmaceutical asset management company. I have great respect for Mark Gabrielson and the management team he has put in place, and I look forward to working with them and my fellow board members to build company value.”



surf's up......crikey



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.